AbbVie posts Q4 beat as Humira outperforms
Source: SeekingAlpha
2026-02-04 08:24:03 ET
More on AbbVie
- AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- AbbVie: The Dividend Does Not Lie
- AbbVie: Rocky Near-Term, Positive Long-Term
- AbbVie Non-GAAP EPS of $2.71 beats by $0.06, revenue of $16.62B beats by $200M
- AbbVie Q4 Preview: Here's what to expect
Read the full article on Seeking Alpha
For further details see:
AbbVie posts Q4 beat as Humira outperforms
AbbVie Inc.
NASDAQ: ABBV
ABBV Trading
-0.97% G/L:
$224.48 Last:
1,406,476 Volume:
$226.89 Open:
ABBV Latest News
March 13, 2026 01:36:56 pm
Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities
ABBV Stock Data
$396,361,630,803
1,749,710,786
N/A
2503
N/A
Pharmaceuticals
Healthcare
US
North Chicago
